HPV Types 16 and 18 Vaccine Cervarix Gets FDA Approval for Use in Cervical Cancer Prevention

Links shared publicly online about this topic

FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine

drugs.com — “Cervarix (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is used for prevention of cervical cancer. Includes Cervarix side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 10:45 pm By:

drugscom Drugs.com Health Site

FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine - http://bit.ly/2Y6rH0

3 years ago...

Cervarix approved for prevention of HPV-associated cervical cancer - MPR

empr.com — “The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and women 10"25 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 8:55 pm By:

eMPR MPR Medical Publisher

MPR News: Cervarix approved for prevention of HPV-associated cervical cancer: The FDA has approved Cerv.. http://bit.ly/WF8uF

3 years ago...

FDA Approves New Vaccine for Prevention of Cervical Cancer

fda.gov — “The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on October 19, 2009 at 4:49 pm By:

Nurse_com Gannett Healthcare Health News

FDA Approves Cervarix Vaccine for Prevention of Cervical Cancer: http://bit.ly/3aQ67b

3 years ago...

FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters

reuters.com — “PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX [Human papillomavirus bivalent (typesView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 4:16 pm By:

sknews Skin & Allergy News Health News

RT @Apfeiffer: RT @cancercures: FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine http://bit.ly/3PBG9D

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390